210 related articles for article (PubMed ID: 10699107)
41. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
[TBL] [Abstract][Full Text] [Related]
42. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.
Bhandari V; Bergqvist LL; Kronsberg SS; Barton BA; Anand KJ;
Pediatrics; 2005 Aug; 116(2):352-9. PubMed ID: 16061589
[TBL] [Abstract][Full Text] [Related]
43. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
44. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
45. A randomized, controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome.
Egerman RS; Mercer BM; Doss JL; Sibai BM
Am J Obstet Gynecol; 1998 Nov; 179(5):1120-3. PubMed ID: 9822485
[TBL] [Abstract][Full Text] [Related]
46. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
47. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
Papile LA; Tyson JE; Stoll BJ; Wright LL; Donovan EF; Bauer CR; Krause-Steinrauf H; Verter J; Korones SB; Lemons JA; Fanaroff AA; Stevenson DK
N Engl J Med; 1998 Apr; 338(16):1112-8. PubMed ID: 9545359
[TBL] [Abstract][Full Text] [Related]
48. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
49. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
50. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
[TBL] [Abstract][Full Text] [Related]
51. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
Pappagallo M; Abbasi S; Bhutani VK
Indian J Pediatr; 1998; 65(2):273-82. PubMed ID: 10771973
[TBL] [Abstract][Full Text] [Related]
52. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone.
De Laet MH; Dassonville M; Johansson A; Lerminiaux C; Seghers V; Van den Eijnden S; Blum D; Vanderwinden JM
Eur J Pediatr Surg; 2000 Oct; 10(5):323-7. PubMed ID: 11194544
[TBL] [Abstract][Full Text] [Related]
53. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
[TBL] [Abstract][Full Text] [Related]
54. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
55. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
Smith LM; Qureshi N; Chao CR
J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
[TBL] [Abstract][Full Text] [Related]
56. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity.
Kovács L; Davis GM; Faucher D; Papageorgiou A
Acta Paediatr; 1998 Jul; 87(7):792-8. PubMed ID: 9722255
[TBL] [Abstract][Full Text] [Related]
58. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM
Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599
[TBL] [Abstract][Full Text] [Related]
59. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study.
Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z
Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103
[TBL] [Abstract][Full Text] [Related]
60. Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial.
Yaseen H; Okash I; Hanif M; al-Umran K; al-Faraidy A
J Trop Pediatr; 1999 Oct; 45(5):304-6. PubMed ID: 10584476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
